Cardiovascular disease; European society of cardiology; Health infrastructure; Mortality • morbidity; Risk factors; Service provision; Statistics; Article; Europe; World Health Organization
Timmis, A.; Barts Heart Centre, Queen Mary University London, London, United Kingdom
Townsend, N.; Department for Health, University of Bath, Bath, United Kingdom
Gale, C. P.; Medical Research Council Bioinformatics Centre, Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom
Torbica, A.; Centre for Research on Health and Social Care Management (CERGAS), Bocconi University, Milan, Italy
Lettino, M.; San Gerardo Hospital, Monza, Italy
Petersen, S. E.; Barts Heart Centre, Queen Mary University London, London, United Kingdom
Mossialos, E. A.; Department of Health Policy, London School of Economics, London, United Kingdom
Maggioni, A. P.; Research Center of Italian Association of Hospital Cardiologists (ANMCO), Florence, Italy
Kazakiewicz, D.; Barts Heart Centre, Queen Mary University London, London, United Kingdom
May, H. T.; Barts Heart Centre, Queen Mary University London, London, United Kingdom
De Smedt, D.; Department of Public Health and Primary Care, Ghent University, Ghent, Belgium
Flather, M.; Norwich Medical School, University of East Anglia, Norwich, United Kingdom
Zuhlke, L.; Red Cross Children's Hospital, University of Cape Town, Cape Town, South Africa
Beltrame, J. F.; University of Adelaide, Central Adelaide Local Health Network, Queen Elizabeth Hospital, Adelaide, Australia
Huculeci, R.; European Society of Cardiology Health Policy Unit European Heart Health Institute, European Heart Agency, Brussels, Belgium
Tavazzi, L.; Maria Cecilia Hospital-GVM Care&Research, Cotignola, Italy
Hindricks, G.; University of Leipzig, Leipzig, Germany
Bax, J.; Leiden University Medical Center, Leiden, Netherlands
Casadei, B.; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Level 6, West Wing, Oxford, United Kingdom
Wright, L.; Nuffield Department of Population Health, University of Oxford, Headington, Oxford, United Kingdom
Vardas, P.; European Society of Cardiology Health Policy Unit European Heart Health Institute, European Heart Agency, Brussels, Belgium
Mimoza, L.; Albania
Artan, G.; Albania
Aurel, D.; Albania
Chettibi, M.; Algeria
Hammoudi, N.; Algeria
Sisakian, H.; Armenia
Pepoyan, S.; Armenia
Metzler, B.; Austria
Siostrzonek, P.; Austria
Weidinger, F.; Austria
Jahangirov, T.; Azerbaijan
Aliyev, F.; Azerbaijan
Rustamova, Y.; Azerbaijan
Mrochak, N. M. A.; Belarus
Lancellotti, Patrizio ; Université de Liège - ULiège > Département des sciences cliniques > Cardiologie - Pathologie spéciale et réhabilitation
Pasquet, A.; Belgium
Claeys, M.; Belgium
Kusljugic, Z.; Bosnia and Herzegovina
Hudic, L. D.; Bosnia and Herzegovina
Smajic, E.; Bosnia and Herzegovina
Tokmakova, M. P.; Bulgaria
Gatzov, P. M.; Bulgaria
Milicic, D.; Croatia
Bergovec, M.; Croatia
Christou, C.; Cyprus
Moustra, H. H.; Cyprus
Christodoulides, T.; Cyprus
Linhart, A.; Czech Republic
Taborsky, M.; Czech Republic
Abdelhamid, M.; Egypt
Shokry, K.; Egypt
Kampus, P.; Estonia
Viigimaa, M.; Estonia
Ryödi, E.; Finland
Niemela, M.; Finland
Rissanen, T. T.; Finland
Le Heuzey, J.-Y.; France
Gilard, M.; France
Aladashvili, A.; Georgia
Gamkrelidze, A.; Georgia
Kereselidze, M.; Georgia
Zeiher, A.; Intermountain Medical Center Heart Institute, Salt Lake City, UT, United States
Katus, H.; Intermountain Medical Center Heart Institute, Salt Lake City, UT, United States
Bestehorn, K.; Intermountain Medical Center Heart Institute, Salt Lake City, UT, United States
Tsioufis, C.; Greece
Goudevenos, J.; Greece
Csanádi, Z.; Hungary
Becker, D.; Hungary
Tóth, K.; Hungary
Hrafnkelsdóttir, P. J.; Iceland
Crowley, J.; Ireland
Kearney, P.; Ireland
Dalton, B.; Ireland
Zahger, D.; Israel
Wolak, A.; Israel
Gabrielli, D.; Italy
Indolfi, C.; Italy
Urbinati, S.; Italy
Imantayeva, G.; Kazakhstan
Berkinbayev, S.; Kazakhstan
Bajraktari, G.; Kosovo, Serbia
Ahmeti, A.; Kosovo, Serbia
Berisha, G.; Kosovo, Serbia
Erkin, M.; Kyrgyzstan
Saamay, A.; Kyrgyzstan
Erglis, A.; Latvia
Bajare, I.; Latvia
Jegere, S.; Latvia
Mohammed, M.; Lebanon
Sarkis, A.; Lebanon
Saadeh, G.; Lebanon
Zvirblyte, R.; Lithuania
Sakalyte, G.; Lithuania
Slapikas, R.; Lithuania
Ellafi, K.; Libyan Arab Jamahiriya
El Ghamari, F.; Libyan Arab Jamahiriya
Banu, C.; Luxembourg
Beissel, J.; Luxembourg
Felice, T.; Malta
Buttigieg, S. C.; Malta
Xuereb, R. G.; Malta
Popovici, M.; Moldova
Boskovic, A.; Montenegro
Rabrenovic, M.; Montenegro
Ztot, S.; Morocco
Abir-Khalil, S.; Morocco
Van Rossum, A. C.; Netherlands
Mulder, B. J. M.; Netherlands
Elsendoorn, M. W.; Netherlands
Srbinovska-Kostovska, E.; North Macedonia
Kostov, J.; North Macedonia
Marjan, B.; North Macedonia
Steigen, T.; Norway
Mjølstad, O. C.; Norway
Ponikowski, P.; Poland
Witkowski, A.; Poland
Jankowski, P.; Poland
Gil, V. M.; Portugal
Mimoso, J.; Portugal
Baptista, S.; Portugal
Vinereanu, D.; Romania
Chioncel, O.; Romania
Popescu, B. A.; Romania
Shlyakhto, E.; Russian Federation
Oganov, R.; Russian Federation
Foscoli, M.; San Marino
Zavatta, M.; San Marino
Dikic, A. D.; Serbia
Beleslin, B.; Serbia
Radovanovic, M. R.; Serbia
Hlivak, P.; Slovakia
Hatala, R.; Slovakia
Kaliska, G.; Slovakia
Kenda, M.; Slovenia
Fras, Z.; Slovenia
Anguita, M.; Spain
Cequier, A.; Spain
Muniz, J.; Spain
James, S.; Sweden
Johansson, B.; Sweden
Platonov, P.; Sweden
Zellweger, M. J.; Switzerland
Pedrazzini, G. B.; Switzerland
Carballo, D.; Switzerland
Shebli, H. E.; Syrian Arab Republic
Kabbani, S.; Syrian Arab Republic
Abid, L.; Tunisia
Addad, F.; Tunisia
Bozkurt, E.; Turkey
Kayikçioǧlu, M.; Turkey
Erol, M. K.; Turkey
Kovalenko, V.; Ukraine
Nesukay, E.; Ukraine
Wragg, A.; United Kingdom
Ludman, P.; United Kingdom
Ray, S.; United Kingdom
Kurbanov, R.; Uzbekistan
Boateng, D.; Atlas
Daval, G.; Atlas
De Benito Rubio, V.; Atlas
Sebastiao, D.; Atlas
De Courtelary, P. T.; Atlas
Bardinet, I.; Atlas
The ESC Atlas of Cardiology is a compendium of cardiovascular statistics compiled by the European Heart Agency, A Department Of The European Society Of Cardiology
Timmis A, Townsend N, Gale C, Grobbee R, Maniadakis N, Flather M, Wilkins E, Wright L, Vos R, Bax J, Blum M, Pinto F, Vardas P; ESC Scientific Document Group. European Society of Cardiology: cardiovascular disease statistics 2017. Eur Heart J 2018;39:508579.
Vardas P, Maniadakis N, Bardinet I, Pinto F. The European Society of Cardiology Atlas of Cardiology: rational, objectives, and methods. Eur Heart J Qual Care Clin Outcomes 2016;2:615.
The World Bank. Classifying countries by income. http://datatopics.worldbank.org/world-development-indicators/stories/the-classification-of-countries-by-income.html.
Wilkins E, Wilson L, Wickramasinghe K, Bhatnagar P, Leal J, Luengo-Fernandez R, Burns R, Rayner M, Townsend N. European Cardiovascular Disease Statistics 2017. Brussels: European Heart Network; 2017.
Centre for Economics and Business Research. The economic cost of cardiovascular disease from 20142020 in six European economies; 2014. https://www.cebr.com/wp-content/uploads/2015/08/Short-Report-18.08.14.pdf (24 August 2019).
Jayawardana S, Cylus J, Mossialos E. It’s not ageing, stupid: why population ageing won’t bankrupt health systems. Eur Heart J Qual Care Clin Outcomes 2019;5:195201.
Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937952.
World Health Organization. Noncommunicable diseases: Campaign for action—meeting the NCD targets. https://www.who.int/beat-ncds/take-action/targets/en/.
Timmis AD, English KM. Women in cardiology: a UK perspective. Heart 2005;91:273274.
Burgess S, Shaw E, Ellenberger K, Thomas L, Grines C, Zaman S. Women in medicine: addressing the gender gap in interventional cardiology. J Am Coll Cardiol 2018;72:26632667.
Timmis A, Gale CP, Flather M, Maniadakis N, Vardas P. Cardiovascular disease statistics from the European atlas: inequalities between high- and middle-income member countries of the ESC. Eur Heart J Qual Care Clin Outcomes 2018;4:13.
Tudor Hart J. The inverse care law. Lancet 1971;297:405412.
Mendis S, Puska P, Norrving B, eds. Global Atlas on Cardiovascular Disease Prevention and Control. Geneva: World Health Organization; 2011.
World Bank. Population estimates and projections. https://datacatalog.worldbank.org/dataset/population-estimates-and-projections.
WHO Mortality Database. https://www.who.int/healthinfo/statistics/mortality_rawdata/en/(29 October 2019).
Office for National Statistics. Revised European Standard Population 2013. https://ec.europa.eu/eurostat/documents/3859598/5926869/KS-RA-13-028-EN.PDF/e713fa79-1add-44e8-b23d-5e8fa09b3f8f (10 October 2019).
WHO methods and data sources for country-level causes of death 2000-2016. Department of Information, Evidence and Research WHO, Geneva, March 2018. https://www.who.int/healthinfo/global_burden_disease/GlobalCOD_method_2000-2016.pdf (3 September 2019)
NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet 2016;387:15131530.
NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 191 million participants. Lancet 2017;389:3755.
IHME—measuring what matters. http://www.healthdata.org.
GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016;388:14591544.
Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, Ahmed M, Aksut B, Alam T, Alam K, Alla F, Alvis-Guzman N, Amrock S, Ansari H, Arnl€öv J, Asayesh H, Atey TM, Avila-Burgos L, Awasthi A, Banerjee A, Barac A, B€arnighausen T, Barregard L, Bedi N, Belay Ketema E, Bennett D, Berhe G, Bhutta Z, Bitew S, Carapetis J, Carrero JJ, Malta DC, Castañeda-Orjuela CA, Castillo-Rivas J, Catala-Lopez F, Choi JY, Christensen H, Cirillo M, Cooper L Jr, Criqui M, Cundiff D, Damasceno A, Dandona L, Dandona R, Davletov K, Dharmaratne S, Dorairaj P, Dubey M, Ehrenkranz R, El Sayed Zaki M, Faraon EJA, Esteghamati A, Farid T, Farvid M, Feigin V, Ding EL, Fowkes G, Gebrehiwot T, Gillum R, Gold A, Gona P, Gupta R, Habtewold TD, Hafezi-Nejad N, Hailu T, Hailu GB, Hankey G, Hassen HY, Abate KH, Havmoeller R, Hay SI, Horino M, Hotez PJ, Jacobsen K, James S, Javanbakht M, Jeemon P, John D, Jonas J, Kalkonde Y, Karimkhani C, Kasaeian A, Khader Y, Khan A, Khang YH, Khera S, Khoja AT, Khubchandani J, Kim D, Kolte D, Kosen S, Krohn KJ, Kumar GA, Kwan GF, Lal DK, Larsson A, Linn S, Lopez A, Lotufo PA, El Razek HMA, Malekzadeh R, Mazidi M, Meier T, Meles KG, Mensah G, Meretoja A, Mezgebe H, Miller T, Mirrakhimov E, Mohammed S, Moran AE, Musa KI, Narula J, Neal B, Ngalesoni F, Nguyen G, Obermeyer CM, Owolabi M, Patton G, Pedro J, Qato D, Qorbani M, Rahimi K, Rai RK, Rawaf S, Ribeiro A, Safiri S, Salomon JA, Santos I, Santric Milicevic M, Sartorius B, Schutte A, Sepanlou S, Shaikh MA, Shin MJ, Shishehbor M, Shore H, Silva DAS, Sobngwi E, Stranges S, Swaminathan S, Tabarés-Seisdedos R, Tadele Atnafu N, Tesfay F, Thakur JS, Thrift A, Topor-Madry R, Truelsen T, Tyrovolas S, Ukwaja KN, Uthman O, Vasankari T, Vlassov V, Vollset SE, Wakayo T, Watkins D, Weintraub R, Werdecker A, Westerman R, Wiysonge CS, Wolfe C, Workicho A, Xu G, Yano Y, Yip P, Yonemoto N, Younis M, Yu C, Vos T, Naghavi M, Murray C. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol 2017;70:125.
Mathers CD, Salomon JA, Ezzati M, Begg S, Hoorn S V, Lopez AD. Sensitivity and uncertainty analyses for burden of disease and risk factor estimates. 2006. http://www.ncbi.nlm.nih.gov/pubmed/21250370 (10 September 2019).
Solberg CT, Norheim OF, Barra M. The disvalue of death in the global burden of disease. J Med Ethics 2018;44:192198.
World Bank—Data Bank. https://databank.worldbank.org/home.aspx (15 October 2019).
Cleveland WS. Robust locally weighted regression and smoothing scatter-plots. J Am Stat Assoc 1979;74:829836.
Timmis A. Cardiovascular mortality in the UK: good news if you live in the South. Heart 2015;101:11801181.
Vaez M, Dalén M, Friberg O, € Nilsson J, Frøbert O, Lagerqvist B, Ivert T. Regional differences in coronary revascularization procedures and outcomes: a nationwide 11-year observational study. Eur Heart J Qual Care Clin Outcomes 2017;3:243248.
Gheorghe A, Griffiths U, Murphy A, Legido-Quigley H, Lamptey P, Perel P. The economic burden of cardiovascular disease and hypertension in low- and middle-income countries: a systematic review. BMC Public Health 2018;18:975.
Leal J, Luengo-Fernandez R, Gray A, Petersen S, Rayner M. Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J 2006;27:16101619.
Current health expenditure (% of GDP) from The World Bank. https://data.worldbank.org/indicator/SH.XPD.CHEX.GD.ZS (23 November 2019).
World Health Organization. Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%) (Health financing). http://apps.who.int/gho/data/node.imr.GHED_CHEGDP_SHA2011?lang=en (23 November 2019).
OECD, Eurostat and World Health Organization. A System of Health Accounts 2011: Revised edition. Paris: OECD Publishing, 2017. http://dx.doi.org/10.1787/9789264270985-en (25 November 2019).
OECD, Estimating expenditure by disease, age and gender under the system of health accounts (SHA) framework. 2008. https://www.oecd.org/els/health-systems/EstimatingExpenditurebyDiseaseAgeandGender_FinalReport.pdf (25 November 2019).
OECD. Expenditure by disease, age and gender—focus on health spending. 2016. https://www.oecd.org/els/health-systems/estimating-expenditure-by-disease-age-and-gender.htm (25 November 2019).
Eurostat. HEDIC: Health Expenditures by Diseases and Conditions. 2016. https://ec.europa.eu/eurostat/documents/3888793/7605571/KS-TC-16-008-EN-N.pdf/6cb33aa4-2e65-4df7-9b2b-1ff171eb1fba (25 November 2019).
Nichols M, Townsend N, Luengo-Fernandez R, Leal J, Gray A, Scarborough P., Rayner M. European Cardiovascular Disease Statistics 2012. European Heart Network, Brussels and European Society of Cardiology, Sophia Antipolis; 2012. https://www.escardio.org/static_file/Escardio/Press-media/press-releases/2013/EU-cardiovascular-disease-statistics-2012.pdf (25 November 2019).
Health matters: preventing cardiovascular disease—GOV.UK. https://www.gov.uk/government/publications/health-matters-preventing-cardiovascular-disease/health-matters-preventing-cardiovascular-disease (10 September 2019).
Tuppin P, Rivière S, Rigault A, Tala S, Drouin J, Pestel L, Denis P, Gastaldi-Ménager C, Gissot C, Juillière Y, Fagot-Campagna A. Prevalence and economic burden of cardiovascular diseases in France in 2013 according to the national health insurance scheme database. Arch Cardiovasc Dis 2016;109:399411.
Einarson TR, Acs A, Ludwig C, Panton UH. Economic burden of cardiovascular disease in type 2 diabetes: a systematic review. Value Health 2018;21:881890.
Anand SS, Yusuf S. Stemming the global tsunami of cardiovascular disease. Lancet 2011;377: 529532.
World Heart Federation: Champion Advocates Programme. The costs of CVD. http://www.championadvocates.org/en/champion-advocates-programme/thecosts-of-CVD.
Mahmood SS, Levy D, Vasan RS, Wang TJ. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet 2014;383:9991008.
Damen JA, Hooft L, Schuit E, Debray TP, Collins GS, Tzoulaki I, Lassale CM, Siontis GC, Chiocchia V, Roberts C, Schlüssel MM, Gerry S, Black JA, Heus P, van der Schouw YT, Peelen LM, Moons KG. Prediction models for cardiovascular disease risk in the general population: systematic review. BMJ 2016;353:i2416.
Pencina MJ, Navar AM, Wojdyla D, Sanchez RJ, Khan I, Elassal J, D’Agostino B Sr, Peterson ED, Sniderman AD. Quantifying importance of major risk factors for coronary heart disease. Circulation 2019;139:16031611.
May HT, Horne BD, Knight S, Knowlton KU, Bair TL, Lappé DL, Le VT, Muhlestein JB. The association of depression at any time to the risk of death following coronary artery disease diagnosis. Eur Heart J Qual Care Clin Outcomes 2017;3:296302.
Jensen MT, Marott JL, Holtermann A, Gyntelberg F. Living alone is associated with all-cause and cardiovascular mortality: 32 years of follow-up in the Copenhagen Male Study. Eur Heart J Qual Care Clin Outcomes 2019;5:208217.
Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:19031913.
Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, Alexander L, Estep K, Hassen Abate K, Akinyemiju TF, Ali R, Alvis-Guzman N, Azzopardi P, Banerjee A, B€arnighausen T, Basu A, Bekele T, Bennett DA, Biadgilign S, Catala-Lopez F, Feigin VL, Fernandes JC, Fischer F, Gebru AA, Gona P, Gupta R, Hankey GJ, Jonas JB, Judd SE, Khang Y-H, Khosravi A, Kim YJ, Kimokoti RW, Kokubo Y, Kolte D, Lopez A, Lotufo PA, Malekzadeh R, Melaku YA, Mensah GA, Misganaw A, Mokdad AH, Moran AE, Nawaz H, Neal B, Ngalesoni FN, Ohkubo T, Pourmalek F, Rafay A, Rai RK, Rojas-Rueda D, Sampson UK, Santos IS, Sawhney M, Schutte AE, Sepanlou SG, Shifa GT, Shiue I, Tedla BA, Thrift AG, Tonelli M, Truelsen T, Tsilimparis N, Ukwaja KN, Uthman OA, Vasankari T, Venketasubramanian N, Vlassov VV, Vos T, Westerman R, Yan LL, Yano Y, Yonemoto N, Zaki ME, Murray CJ. Global Burden of Hypertension and Systolic Blood Pressure of at least 110 to 115 mmHg, 1990-2015. JAMA 2017;317:165182.
Xie X, Atkins E, Lv J, Bennett A, Neal B, Ninomiya T, Woodward M, MacMahon S, Turnbull F, Hillis GS, Chalmers J, Mant J, Salam A, Rahimi K, Perkovic V, Rodgers A. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis. Lancet 2016;387:435443.
Stamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356 222 primary screenees of the multiple risk factor intervention trial (MRFIT). JAMA 1986;256:28232828.
Ference BA, Yoo W, Alesh I, Mahajan N, Mirowska KK, Mewada A, Kahn J, Afonso L, Williams KA Sr, Flack JM. Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis. J Am Coll Cardiol 2012;60:26312639.
Cholesterol Treatment Trialists’ (CTT) Collaborators, Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, Barnes EH, Voysey M, Gray 3A, Collins R, Baigent C. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 2012;380:581590.
Cholesterol Treatment Trialists’ (CTT) Collaboration, Fulcher J, O’Connell R, Voysey M, Emberson J, Blackwell L, Mihaylova B, Simes J, Collins R, Kirby A, Colhoun H, Braunwald E, La Rosa J, Pedersen TR, Tonkin A, Davis B, Sleight P, Franzosi MG, Baigent C, Keech 3A. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials. Lancet 2015;385:13971405.
Silverman MG, Ference BA, Im K, Wiviott SD, Giugliano RP, Grundy SM, Braunwald E, Sabatine MS. Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions. A systematic review and meta-analysis. JAMA 2016;316:12891297.
World Health Organization. Global Health Observatory (GHO) data. http://www.who.int/gho/ncd/risk_factors/cholesterol_prevalence/en/(30 August 2019).
World Health Organizzationniation data and statistics. The challenge of diabetes. http://www.euro.who.int/en/health-topics/noncommunicable-diseases/diabetes/data-and-statistics (30 August 2019).
NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 192 million participants. Lancet 2016;387:13771396.
Malik VS, Willet WC, Hu FB. Global Obesity: trends, risk factors and policy implications. Nat Rev Endocrinol 2013;9:1327.
Global BMI Mortality Collaboration, Di Angelantonio E, Bhupathiraju SN, Wormser D, Gao P, Kaptoge S, de Gonzalez AB, Cairns BJ, Huxley R, Jackson CL, Joshy G, Lewington S, Manson JE, Murphy N, Patel AV, Samet JM, Woodward M, Zheng W, Zhou M, Bansal N, Barricarte A, Carter B, Cerhan JR, Collins R, Smith GD, Fang X, Franco OH, Green J, Halsey J, Hildebrand JS, Jung KJ, Korda RJ, McLerran DF, Moore SC, O’Keeffe LM, Paige E, Ramond A, Reeves GK, Rolland B, Sacerdote C, Sattar N, Sofianopoulou E, Stevens J, Thun M, Ueshima H, Yang L, Yun YD, Willeit P, Banks E, Beral V, Chen Z, Gapstur SM, Gunter MJ, Hartge P, Jee SH, Lam T-H, Peto R, Potter JD, Willett WC, Thompson SG, Danesh J, Hu FB. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet 2016;388:776786.
European Commission: Eurostat. Tobacco consumption statistics. 2014. https://ec.europa.eu/eurostat/statistics-explained/index.php/Tobacco_consumption_statistics#Daily_smokers_of_cigarettes (25 November 2019).
Hoffman SJ, Tan C. Overview of systematic reviews on the health-related effects of government tobacco control policies. BMC Public Health 2015;15:744.
European Commission. European core health indicators. https://ec.europa.eu/health/indicators_data/echi_en (25 November 2019).
Stahre M, Roeber J, Kanny D, Brewer RD, Zhang X. Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States. Prev Chronic Dis 2014;11:E109.
Anderson P, Baumberg B. Alcohol in Europe. London: Institute of Alcohol Studies; 2006. https://ec.europa.eu/health/archive/ph_determinants/life_style/alcohol/documents/alcohol_europe_en.pdf (25 November 2019).
Miller V, Mente A, Dehghan M, Rangarajan S, Zhang X, Swaminathan S; Prospective Urban Rural Epidemiology (PURE) study investigators. Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study. Lancet 2017;39:20372049.
Threapleton DE, Greenwood DC, Evans CE, Cleghorn CL, Nykjaer C, Woodhead C, Cade JE, Gale CP, Burley VJ. Dietary fibre intake and risk of cardiovascular disease: systematic review and meta-analysis. BMJ 2013;347:f6879.
Aune D, Giovannucci E, Boffetta P, Fadnes LT, Keum NNa, Norat T, Greenwood DC, Riboli E, Vatten LJ, Tonstad S. Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all-cause mortality—a systematic review and dose-response meta-analysis of prospective studies. Int J Epidemiol 2017;46:10291056.
Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT; Lancet Physical Activity Series Working Group. Effect of physical inactivity on major noncommunicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet 2012;380:219229.
Hamer M, O’Donovan G, Murphy M. Physical inactivity and the economic and health burdens due to cardiovascular disease: exercise as medicine. Adv Exp Med Biol 2017;999:318.
Coggon D, Barker D, Rose G. Epidemiology for the Uninitiated. London: John Wiley & Sons; 2009.
GBD 2017 Mortality Collaborators. Global, regional, and national age-sex-specific mortality and life expectancy, 19502017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392:16841735.
GBD 2015 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 19902015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016;388:160358.
Dicker D, Nguyen G, Lopez AD, Murray CJ. Another blow to credibility in published data sources—author’s reply. Lancet 2019;394:2728.
Rigby M, Deshpande S, Blair M. Another blow to credibility in published data sources. Lancet 2019;394:2627.
World Health Organization. Metrics: disability-adjusted life year (DALY). Quantifying the burden of disease from mortality and morbidity. https://www.who.int/healthinfo/global_burden_disease/metrics_daly/en/(25 November 2019).
Smolina K, Wright FL, Rayner M, Goldacre MJ. Determinants of the decline in mortality from acute myocardial infarction in England between 2002 and 2010: linked national database study. BMJ 2012;344:d8059.
O’Flaherty M, Buchan I, Capewell S. Contributions of treatment and lifestyle to declining CVD mortality: why have CVD mortality rates declined so much since the 1960s? Heart 2013;99:159162.
Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL; ESC Scientific Document Group. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2016;37:23152381.
Turakhia MP, Shafrin J, Bognar K, Trocio J, Abdulsattar Y, Wiederkehr D, Goldman DP. Estimated prevalence of undiagnosed atrial fibrillation in the United States. PLoS One 2018;13:e0195088.
Mikkelsen L, Lopez A, Phillips D. Why birth and death registration really are vital statistics development. United Nations Development Programme: Human Development Report. http://hdr.undp.org/en/content/why-birth-and-death-registration-really-are-“vital”-statistics-development (25 November 2019).
Abouzahr C, Mikkelsen L, Rampatige R, Lopez A. Mortality statistics: a tool to enhance understanding and improve quality. Pac Health Dialog 2012;18:247270.
Bhalla K, Harrison JE, Shahraz S, Fingerhut LA. Availability and quality of cause-of-death data for estimating the global burden of injuries. Bull World Health Organ 2010;88:831838.
Nichols M, Townsend N, Scarborough P, Rayner M. Trends in age-specific coronary heart disease mortality in the European Union over three decades: 19802009. Eur Heart J 2013;34:30173027.
Shah R, Wilkins E, Nichols M, Kelly P, El-Sadi F, Wright FL, Townsend N. Epidemiology report: trends in sex-specific cerebrovascular disease mortality in Europe based on WHO mortality data. Eur Heart J 2019;40:755764.
Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J 2016;37:32323245.
Jaul E, Barron J. Age-related diseases and clinical and public health implications for the 85 years old and over population. Front Public Health 2017;5:335.
Cao B, Bray F, Ilbawi A, Soerjomataram I. Effect on longevity of one-third reduction in premature mortality from non-communicable diseases by 2030: a global analysis of the Sustainable Development Goal health target. Lancet Glob Health 2018;6:e1288e1296.
Bhatnagar P, Wickramasinghe K, Wilkins E, Townsend N. Trends in the epidemiology of cardiovascular disease in the UK. Heart 2016;102:19451952.
WHO. NCD Global monitoring framework. Ensuring progress on noncommunicable diseases in countries. https://www.who.int/nmh/global_monitoring_framework/en/(25 November 2019).
Gardner JW, Sanborn JS. Years of potential life lost (YPLL)—what does it measure? Epidemiology 1990;1:322329.
Tadayon S, Wickramasinghe K, Townsend N. Examining trends in cardiovascular disease mortality across Europe: how does the introduction of a new European Standard Population affect the description of the relative burden of cardiovascular disease? Popul Health Metr 2019;17:6.
Pace M, Lanzieri G, Glickman M, Grande E, Zupanic T, Wojtyniak B. Revision of the European Standard Population - Report of the Eurostat’s task force—2013 edition. https://ec.europa.eu/eurostat/web/products-manuals-and-guidelines/-/KS-RA-13-028 (25 November 2019).
Garcia M, Mulvagh SL, Bairey Merz CN, Buring JE, Manson JE. Cardiovascular disease in women: clinical perspectives. Circ Res 2016;118:12731293.
Unal B, Erkoyun E, Maximova K, Farrington J, Loyola E, Critchley J, Capewell S, Galea G. Impact of NCD policies on ischaemic heart disease and premature NCD mortality change in Europe: Belgin Unal. Eur J Public Health 2017;27:142.
Zhang X, Khan AA, Haq EU, Rahim A, Hu D, Attia J, Oldmeadow C, Ma X, Ding R, Boyle AJ. Increasing mortality from ischaemic heart disease in China from 2004 to 2010: disproportionate rise in rural areas and elderly subjects. 438 million person-years follow-up. Eur Heart J Qual Care Clin Outcomes 2017;3:4752.
Global spending on healthcare by continent and country—Emergo. https://www.emergobyul.com/resources/worldwide-health-expenditures (31 August 2019).
Jayawardana S, Cylus J, Mossialos E. It’s not ageing, stupid: why population ageing won’t bankrupt health systems. Eur Heart J Qual Care Clin Outcomes 2019;5:195201.
NICE quality standard 9. Chronic heart failure quality standard. Issued: June 2011 guidance. nice.org.uk/qs9 (25 November 2019).
Schiele F, Gale CP, Bonnefoy E, Capuano F, Claeys MJ, Danchin N, Fox KA, Huber K, Iakobishvili Z, Lettino M, Quinn T, Rubini Gimenez M, Bøtker HE, Swahn E, Timmis A, Tubaro M, Vrints C, Walker D, Zahger D, Zeymer U, Bueno H. Quality indicators for acute myocardial infarction: a position paper of the Acute Cardiovascular Care Association. Eur Heart J Acute Cardiovasc Care 2017;6:3459.
Bebb O, Hall M, Fox KAA, Dondo TB, Timmis A, Bueno H, Schiele F, Gale CP. Performance of hospitals according to the ESC ACCA quality indicators and 30-day mortality for acute myocardial infarction: national cohort study using the United Kingdom Myocardial Ischaemia National Audit Project (MINAP) register. Eur Heart J 2017;38:974982.
Kulkarni VT, Ross JS, Wang Y, Nallamothu BK, Spertus JA, Normand SL, Masoudi FA, Krumholz HM. Regional density of cardiologists and rates of mortality for acute myocardial infarction and heart failure. Circ Cardiovasc Qual Outcomes 2013;6:352359.
Timmis AD, English KM. Women in cardiology: a UK perspective. Heart 2005;91:273274.
Burgess S, Shaw E, Ellenberger K, Thomas L, Grines C, Zaman S. Women in medicine: addressing the gender gap in interventional cardiology. J Am Coll Cardiol 2018;72:26632667.
Gialama F, Prezerakos P, Apostolopoulos V, Maniadakis N. Systematic review of the cost-effectiveness of transcatheter interventions for valvular heart disease. Eur Heart J Qual Care Clin Outcomes 2018;4:8190.
Singh K, Bhalla AS, Qutub MA, Carson K, Labinaz M. Systematic review and meta-analysis to compare outcomes between intermediate- and high-risk patients undergoing transcatheter aortic valve implantation. Eur Heart J Qual Care Clin Outcomes 2017;3:289295.
Durko AP, Osnabrugge RL, Van Mieghem NM, Milojevic M, Mylotte D, Nkomo VT, Pieter Kappetein A. Annual number of candidates for transcatheter aortic valve implantation per country: current estimates and future projections. Eur Heart J 2018;39:26352642.
Camm AJ, Nisam S. European utilization of the implantable defibrillator: has 10 years changed the ‘enigma’? Europace 2010;12:10631069.
Stenvall H, Tierala I, R€as€anen P, Laine M, Sintonen H, Roine RP. Long-term clinical outcomes, health-related quality of life, and costs in different treatment modalities of stable coronary artery disease. Eur Heart J Qual Care Clin Outcomes 2017;3:7482.
Leyva F, Qiu T, Evison F, Christoforou C, McNulty D, Ludman P, Ray D. Clinical outcomes and costs of cardiac revascularisation in England and New York state. Open Heart 2018;5:e000704.
Mackay DF, Irfan MO, Haw S, Pell JP. Meta-analysis of the effect of comprehensive smoke-free legislation on acute coronary events. Heart 2010;96:15251530.
World Health Organization. Alcohol policy impact case study: the effects of alcohol control measures on mortality and life expectancy in the Russian Federation (2019). http://www.euro.who.int/en/health-topics/disease-prevention/alcohol-use/publications/2019/alcohol-policy-impact-case-study-the-effects-of-alcohol-control-measures-on-mortality-and-life-expectancy-in-the-russian-federation-2019 (25 November 2019).
Janus B, Rakowski T, Dziewierz A, Fijorek K, Sokolowski A, Dudek D. Effect of introducing a regional 24/7 primary percutaneous coronary intervention service network on treatment outcomes in patients with ST segment elevation myocardial infarction. Kardiol Pol 2015;73:323330.